FDA Should Restore Doctors Rights to Use Medicines That Work

Read more on this subject: Food And Drug Administration / F.D.A
News Story Source: Chessmaster
The FDA has a serious chip on its shoulder regarding the approval process, and its mandate to protect the public by ensuring the safety, efficacy, and security of drugs.  There is clear evidence that its edicts are actually harming the American population, especially with its overreach into the Expanded Access program which allows doctors to choose experimental drugs for their patients.  Leronlimab, a drug developed by CytoDyn, is a perfect example of a very safe and efficacious HIV drug that was repurposed for COVID-19.  It demonstrated its utility in May 2020.  Even though it had 60 emergency INDs (eINDs) more than any drug at the time including remdesivir, the FDA closed it down citing that the high number of eIND's was hurting enrollment in existing clinical trials.  The manuscript by Dr. Otto Yang is the smoking gun evidence that leronlimab worked very early in the pandemic and for some unexplained reason was passed over by the administration.  In
Read More or Make a Comment

Bookmark the permalink.

Comments are closed.